Arcus Biosciences Inc.

NYSE: RCUS · Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM
10.39
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Arcus Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
258M 117M 112M 383M
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
258M 117M 112M 383M
Operating Income
-330M -340M -280M 54M
Interest Income
52M 41M 16M 1M
Pretax Income
-283M -301M -266M 55M
Net Income
-283M -307M -267M 53M
Selling & General & Admin
120M 117M 104M 72M
Research & Development
448M 340M 288M 257M
Other Expenses
20M n/a n/a n/a
Operating Expenses
588M 457M 392M 329M
Interest Expense
4M 2M 2M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
588M 457M 392M 329M
Income Tax Expense
1M 6M 1M 2M
Shares Outstanding (Basic)
90.1M 74M 72M 69.35M
Shares Outstanding (Diluted)
90.1M 74M 72M 73.97M
EPS (Basic)
-3.14 -4.15 -3.71 0.76
EPS (Diluted)
-3.14 -4.15 -3.71 0.71
EBITDA
-269M -291M -258M 59M
EBIT
-279M -299M -264M 55M
Depreciation & Amortization
10M 8M 6M 4M